Clinical Trials Update: Jan. 23, 2007
Alzheimer's Disease Fibrocystic Breast Disease Asthma (Pediatric)
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the safety and effectiveness of an investigational, once-daily medication to treat Alzheimer's disease. Volunteers may be included who are 55 and older, have mild-to-moderate memory problems, and have a reliable caregiver to co-attend visits. The study will last six weeks and include eight office visits. Compensation for time and travel may be provided.
The research site is in Palm Beach Gardens, Fla.
Fibrocystic Breast Disease
This is a study of a biomarker (FibroMax) to predict liver fibrosis, steatosis, and steato-hepatitis in people at risk of non-alcoholic fatty liver disease. The study will include a single blood draw for people with NAFLD who receive a liver biopsy. Blood needs to be drawn within two weeks of biopsy.
The research site is in New York, NY.
This study will evaluate an investigational inhaled asthma medication. Your child may be eligible if the child is between four and 11 years old and has been diagnosed with asthma for at least three months.
The research site is in Dallas, Texas.
Copyright 2007 Thomson CenterWatch. All rights reserved.